Wegovy® 1.7 mg

Almost There — Wegovy® 1.7 mg for Pre-Maintenance Weight Control

Wegovy® 1.7 mg (semaglutide) is the fourth step in the FDA-approved Wegovy titration plan, designed to transition patients smoothly to the full 2.4 mg maintenance dose. At this stage, patients typically experience noticeable body fat reduction, improved satiety, and enhanced metabolic control — all while minimizing gastrointestinal side effects through gradual adjustment.

With just one step left, Wegovy 1.7 mg sets the stage for sustainable, long-term weight management.

Key Benefits

• Supports continued fat loss and appetite suppression
• Prepares body for maximum maintenance dose
• Reduces side effects with stepwise titration
• Once-weekly dosing fits into busy lifestyles
• Proven to aid in BMI reduction and insulin sensitivity

Product Info

• Product Name: Wegovy®
• Active Ingredient: Semaglutide 1.7 mg
• Form: Pre-filled, single-use pen injector
• Strength: 1.7 mg/0.75 mL
• Route: Subcutaneous (SC) injection
• Use: Once weekly (Step 4 of titration)
• Manufacturer: Novo Nordisk
• Storage: Keep refrigerated (2–8°C)

Who It’s For

• Patients completing semaglutide ramp-up phase
• Clinics guiding individuals toward the 2.4 mg maintenance dose
• Those seeing strong results from Wegovy and aiming for long-term transformation

Wegovy 1.7mg Weight Loss Pen – Wholesale & Resell Pricing
Wegovy (semaglutide) 1.7mg is the second-to-last dose in the weekly GLP-1 weight loss protocol. It’s a vital step for patients building toward full treatment with 2.4mg.

Now available for:

• ✅ Wholesale orders

• ✅ Resellers and distributors

• ✅ Clinic use and weight management centers

This pre-filled injection pen delivers safe and effective fat loss with minimal side effects.

• 💉 GLP-1 therapy for appetite control

• 🌍 International shipping

• 💼 Resell-approved packaging

• ⚡ In stock, ready to ship from Korea

Need bulk pricing? Let’s talk wholesale.